Literature DB >> 9811730

Mechanism of interferon action: identification of essential positions within the novel 15-base-pair KCS element required for transcriptional activation of the RNA-dependent protein kinase pkr gene.

K L Kuhen1, J W Vessey, C E Samuel.   

Abstract

RNA-dependent protein kinase PKR is an important regulator of gene expression in interferon (IFN)-treated and virus-infected cells. The 50-kb gene encoding human PKR kinase (pkr) is inducible by IFN. Transfection analyses, using chloramphenicol acetyltransferase (CAT) as the reporter in constructs possessing various 5'-flanking fragments of the human pkr gene, led to the identification of a functional TATA-less promoter that directed IFN-inducible transcription. Sequence determination and mutational analysis of the pkr promoter region revealed, in addition to a functional copy of the IFN-stimulated response element (ISRE) responsible for inducibility by type I IFN, a novel 15-bp element required for optimal promoter activity mediated by the ISRE. This element (5' GGGAAGGCGGAGTCC 3'), designated KCS for kinase-conserved sequence, is exactly conserved between the human and mouse pkr promoters in sequence and position relative to the ISRE. We have now carried out an extensive mutational analysis of the 15-bp KCS element. Site-directed mutagenesis was performed, whereby every base pair position within the KCS element was replaced by each of the other three alternatives. Forty-five substitution mutants were analyzed for promoter activity by transient transfection analysis of untreated and IFN-treated human cells. The results establish 5' NNRRRGG(C,A,T)GGRGYYN 3', where R stands for purine and Y stands for pyrimidine, as the consensus sequence for the KCS element, both for basal and for IFN-inducible promoter activity. KCS-binding proteins were detected by electrophoretic mobility shift analysis (EMSA). Competition EMSA established that constitutively expressed nuclear proteins bound the KCS element selectively; KCS protein binding activity correlated with promoter activity in the transient transfection reporter assay.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811730      PMCID: PMC110506     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR.

Authors:  M Benkirane; C Neuveut; R F Chun; S M Smith; C E Samuel; A Gatignol; K T Jeang
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

2.  Autophosphorylation in the activation loop is required for full kinase activity in vivo of human and yeast eukaryotic initiation factor 2alpha kinases PKR and GCN2.

Authors:  P R Romano; M T Garcia-Barrio; X Zhang; Q Wang; D R Taylor; F Zhang; C Herring; M B Mathews; J Qin; A G Hinnebusch
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

Review 3.  The double-stranded RNA-dependent protein kinase PKR: structure and function.

Authors:  M J Clemens; A Elia
Journal:  J Interferon Cytokine Res       Date:  1997-09       Impact factor: 2.607

4.  Binding of the protein kinase PKR to RNAs with secondary structure defects: role of the tandem A-G mismatch and noncontiguous helixes.

Authors:  P C Bevilacqua; C X George; C E Samuel; T R Cech
Journal:  Biochemistry       Date:  1998-05-05       Impact factor: 3.162

5.  Characterization of the solution complex between the interferon-induced, double-stranded RNA-activated protein kinase and HIV-I trans-activating region RNA.

Authors:  B W Carpick; V Graziano; D Schneider; R K Maitra; X Lee; B R Williams
Journal:  J Biol Chem       Date:  1997-04-04       Impact factor: 5.157

Review 6.  STATs and gene regulation.

Authors:  J E Darnell
Journal:  Science       Date:  1997-09-12       Impact factor: 47.728

7.  Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways.

Authors:  A H Wong; N W Tam; Y L Yang; A R Cuddihy; S Li; S Kirchhoff; H Hauser; T Decker; A E Koromilas
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

8.  Autophosphorylation sites participate in the activation of the double-stranded-RNA-activated protein kinase PKR.

Authors:  D R Taylor; S B Lee; P R Romano; D R Marshak; A G Hinnebusch; M Esteban; M B Mathews
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

9.  Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling.

Authors:  J J Zhang; U Vinkemeier; W Gu; D Chakravarti; C M Horvath; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

10.  Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB.

Authors:  A Kumar; Y L Yang; V Flati; S Der; S Kadereit; A Deb; J Haque; L Reis; C Weissmann; B R Williams
Journal:  EMBO J       Date:  1997-01-15       Impact factor: 11.598

View more
  8 in total

Review 1.  Tipping the balance: antagonism of PKR kinase and ADAR1 deaminase functions by virus gene products.

Authors:  Cyril X George; Zhiqun Li; Kristina M Okonski; Ann M Toth; Ying Wang; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

2.  Protein Kinase R Is Constitutively Expressed in the Human Pancreas.

Authors:  Alexander Jonsson; Erik Yngve; Marie Karlsson; Sofie Ingvast; Oskar Skog; Olle Korsgren
Journal:  J Histochem Cytochem       Date:  2018-09-28       Impact factor: 2.479

3.  A unique ISRE, in the TATA-less human Isg20 promoter, confers IRF-1-mediated responsiveness to both interferon type I and type II.

Authors:  C Gongora; G Degols; L Espert; T D Hua; N Mechti
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

4.  Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible.

Authors:  C X George; C E Samuel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

5.  Geranylgeranylacetone has anti-hepatitis C virus activity via activation of mTOR in human hepatoma cells.

Authors:  Shigeyuki Takeshita; Tatsuki Ichikawa; Naota Taura; Hisamitsu Miyaaki; Toshihisa Matsuzaki; Masashi Otani; Toru Muraoka; Motohisa Akiyama; Satoshi Miuma; Eisuke Ozawa; Masanori Ikeda; Nobuyuki Kato; Hajime Isomoto; Fuminao Takeshima; Kazuhiko Nakao
Journal:  J Gastroenterol       Date:  2011-10-25       Impact factor: 7.527

Review 6.  Antiviral actions of interferons.

Authors:  C E Samuel
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

7.  Organization of the mouse RNA-specific adenosine deaminase Adar1 gene 5'-region and demonstration of STAT1-independent, STAT2-dependent transcriptional activation by interferon.

Authors:  Cyril X George; Sonali Das; Charles E Samuel
Journal:  Virology       Date:  2008-09-06       Impact factor: 3.616

8.  Auto-phosphorylation Represses Protein Kinase R Activity.

Authors:  Die Wang; Nicole A de Weerd; Belinda Willard; Galina Polekhina; Bryan R G Williams; Anthony J Sadler
Journal:  Sci Rep       Date:  2017-03-10       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.